MHC II类风险等位基因与氨基酸残基在特发性膜性肾病中的作用
该研究对261例特发性膜性肾病患者和599名健康对照进行HLA四位点分型,发现DRB1*1501和DRB1*0301为独立风险等位基因,且与循环抗PLA2R抗体相关;MHC-DRβ1链第13和71位氨基酸独立关联,结构模型提示这些残基促进与PLA2R T细胞表位的结合。
要点
- DRB1*1501和DRB1*0301是特发性膜性肾病的独立风险等位基因,且与抗PLA2R抗体相关。
- MHC-DRβ1链第13位和第71位氨基酸独立与特发性膜性肾病关联。
- 结构模型提示DRB1*1501编码的精氨酸13和丙氨酸71、DRB1*0301编码的赖氨酸71促进与PLA2R T细胞表位结合。
核心结论
- 研究识别出两个HLA II类基因风险等位基因及MHC-DRβ1链第13和71位上的三个氨基酸残基,可能通过呈递PLA2R的T细胞表位而赋予特发性膜性肾病易感性。
研究设计与样本
- 对261例特发性膜性肾病患者和599名健康对照在HLA-DRB1、HLA-DQA1、HLA-DQB1和HLA-DPB1位点进行四位分辨率基因分型,并从IMGT/HLA数据库提取编码氨基酸序列。
- 预测PLA2R的T细胞表位,并使用Modeler构建MHC-DR分子-PLA2R肽-T细胞受体结构。
主要发现
- DRB1*1501为特发性膜性肾病独立风险等位基因,比值比4.65(95%CI 3.39至6.41,P<0.001),且与循环抗PLA2R抗体相关。
- DRB1*0301为特发性膜性肾病独立风险等位基因,比值比3.96(95%CI 2.61至6.05,P<0.001),且与循环抗PLA2R抗体相关。
- rs4664308(AA)与HLA-DRB1*1501/DRB1*0301之间存在强基因-基因交互作用。
- MHC-DRβ1链第13位(P<0.001)和第71位(P<0.001)氨基酸独立与特发性膜性肾病关联。
- 结构模型显示DRB1*1501编码的精氨酸13和丙氨酸71、DRB1*0301编码的赖氨酸71促进与PLA2R T细胞表位的相互作用。
关键数值与推荐
- DRB1*1501风险等位基因:比值比4.65(95%CI 3.39至6.41,P<0.001)。
- DRB1*0301风险等位基因:比值比3.96(95%CI 2.61至6.05,P<0.001)。
- MHC-DRβ1链第13位氨基酸与特发性膜性肾病独立关联(P<0.001)。
- MHC-DRβ1链第71位氨基酸与特发性膜性肾病独立关联(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epitopes of phospholipase A2 receptor (PLA2R), the target antigen in idiopathic membranous nephropathy (iMN), must be presented by the HLA-encoded MHC class II molecules to stimulate autoantibody production. A genome-wide association study identified risk alleles at HLA and PLA2R loci, with the top variant rs2187668 within HLA-DQA1 showing a risk effect greater than that of the top variant rs4664308 within PLA2R1. How the HLA risk alleles affect epitope presentation by MHC class II molecules in iMN is unknown. Here, we genotyped 261 patients with iMN and 599 healthy controls at the HLA-DRB1, HLA-DQA1, HLA-DQB1, and HLA-DPB1 loci with four-digit resolution and extracted the encoded amino acid sequences from the IMGT/HLA database. We predicted T cell epitopes of PLA2R and constructed MHC-DR molecule-PLA2R peptide-T cell receptor structures using Modeler. We identified DRB1*1501 (odds ratio, 4.65; 95% confidence interval [95% CI], 3.39 to 6.41; P<0.001) and DRB1*0301 (odds ratio, 3.96; 95% CI, 2.61 to 6.05; P<0.001) as independent risk alleles for iMN and associated with circulating anti-PLA2R antibodies. Strong gene-gene interaction was noted between rs4664308(AA) and HLA-DRB1*1501/DRB1*0301. Amino acid positions 13 (P<0.001) and 71 (P<0.001) in the MHC-DRβ1 chain independently associated with iMN. Structural models showed that arginine13 and alanine71, encoded by DRB1*1501, and lysine71, encoded by DRB1*0301, facilitate interactions with T cell epitopes of PLA2R. In conclusion, we identified two risk alleles of HLA class II genes and three amino acid residues on positions 13 and 71 of the MHC-DRβ1 chain that may confer susceptibility to iMN by presenting T cell epitopes on PLA2R.
引用
- Cui Z, Xie LJ, Chen FJ, et al. MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy. J Am Soc Nephrol. 2016. PMID: 27852637. doi:10.1681/ASN.2016020114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。